Advertisement
The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.

ISHLT consensus statement on donor organ acceptability and management in pediatric heart transplantation

Published:January 31, 2020DOI:https://doi.org/10.1016/j.healun.2020.01.1345
      The number of potential pediatric heart transplant recipients continues to exceed the number of donors, and consequently the waitlist mortality remains significant. Despite this, around 40% of all donated organs are not used and are discarded. This document (62 authors from 53 institutions in 17 countries) evaluates factors responsible for discarding donor hearts and makes recommendations regarding donor heart acceptance. The aim of this statement is to ensure that no usable donor heart is discarded, waitlist mortality is reduced, and post-transplant survival is not adversely impacted.

      KEYWORDS

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Almond CSD
        • Thiagarajan RR
        • Piercey GE
        • et al.
        Waiting list mortality among children listed for heart transplantation in the United States.
        Circulation. 2009; 119: 717-727
        • Shimizu M
        • Nishinaka T
        • Inai K
        • Nakanishi T
        Outcomes in children with advanced heart failure in Japan: importance of mechanical circulatory support.
        Heart Vessels. 2016; 31: 1162-1167
        • Khan AM
        • Green RS
        • Lytrivi ID
        • Sahulee R
        Donor predictors of allograft utilization for pediatric heart transplantation.
        Transpl Int. 2016; 29: 1269-1275
        • Shi WY
        • Rouse M
        • Weintraub RG
        • et al.
        Predictors of outcomes in children awaiting heart transplantation: an experience from a National Paediatric Heart Transplantation Programme.
        Eur J Cardio Thorac Surg. 2016; 49: 1711-1718
        • Smits JM
        • Thul J
        • De Pauw M
        • et al.
        Pediatric heart allocation and transplantation in Eurotransplant.
        Transpl Int. 2014; 27: 917-925
        • Rossano JW
        • Lin KY
        • Paridon SM
        • et al.
        Pediatric heart transplantation from donors with depressed ventricular function: an analysis of the United Network of Organ Sharing Database.
        Circ Heart Fail. 2013; 6: 1223-1229
        • Rana A
        • Fraser CD
        • Scully BB
        • et al.
        Inferior outcomes on the waiting list in low-volume pediatric heart transplant centers.
        Am J Transplant. 2017; 17: 1515-1524
        • Mah D
        • Singh TP
        • Thiagarajan RR
        • et al.
        Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA.
        J Heart Lung Transplant. 2009; 28: 1292-1298
        • Al-Kindi SG
        • El-Amm C
        • Ginwalla M
        • Hoit BD
        • Park SJ
        • Oliveira GH
        Heart transplant outcomes in patients with left ventricular non-compaction cardiomyopathy.
        J Heart Lung Transplant. 2015; 34: 761-765
        • Zangwill SD
        • Naftel D
        • L'Ecuyer T
        • et al.
        Outcomes of children with restrictive cardiomyopathy listed for heart transplant: a multi-institutional study.
        J Heart Lung Transplant. 2009; 28: 1335-1340
        • Dipchand AI
        • Naftel DC
        • Feingold B
        • et al.
        Outcomes of children with cardiomyopathy listed for transplant: a multi-institutional study.
        J Heart Lung Transplant. 2009; 28: 1312-1321
        • Adachi I
        • Khan MS
        • Guzmán-Pruneda FA
        • et al.
        Evolution and impact of ventricular assist device program on children awaiting heart transplantation.
        Ann Thorac Surg. 2015; 99: 635-640
        • Zafar F
        • Castleberry C
        • Khan MS
        • et al.
        Pediatric heart transplant waiting list mortality in the era of ventricular assist devices.
        J Heart Lung Transplant. 2015; 34: 82-88
        • Bailey LL
        • Razzouk AJ
        • Hasaniya NW
        • Chinnock RE
        Pediatric transplantation using hearts refused on the basis of donor quality.
        Ann Thorac Surg. 2009; 87: 1902-1909
        • Smith JW
        • O'Brien KD
        • Dardas T
        • et al.
        Systematic donor selection review process improves cardiac transplant volumes and outcomes.
        J Thorac Cardiovasc Surg. 2016; 151: 238-243
        • Morrison AK
        • Gowda C
        • Tumin D
        • et al.
        Pediatric marginal donor hearts: trends in US national use, 2005-2014.
        Pediatr Transplant. 2018; 22: e13216
        • Kanani M
        • Hoskote A
        • Carter C
        • Burch M
        • Tsang V
        • Kostolny M
        Increasing donor-recipient weight mismatch in pediatric orthotopic heart transplantation does not adversely affect outcome.
        Eur J Cardio Thorac Surg. 2012; 41: 427-434
        • Tang L
        • Du W
        • Delius RE
        • L'Ecuyer TJ
        • Zilberman MV
        Low donor-to-recipient weight ratio does not negatively impact survival of pediatric heart transplant patients.
        Pediatr Transplant. 2010; 14: 741-745
        • Patel A
        • Bock MJ
        • Wollstein A
        • Nguyen K
        • Malerba S
        • Lytrivi ID
        Donor-recipient height ratio and outcomes in pediatric heart transplantation.
        Pediatr Transplant. 2016; 20: 652-657
        • Rossano JW
        • Cherikh WS
        • Chambers DC
        • et al.
        The Registry of the International Society for Heart and Lung Transplantation: twentieth pediatric heart transplantation report-2017; focus theme: allograft ischemic time.
        J Heart Lung Transplant. 2017; 36: 1060-1069
        • Westbrook TC
        • Morales DLS
        • Khan MS
        • et al.
        Interaction of older donor age and survival after weight-matched pediatric heart transplantation.
        J Heart Lung Transplant. 2017; 36: 554-558
        • Krishnamoorthy V
        • Borbely X
        • Rowhani-Rahbar A
        • Souter MJ
        • Gibbons E
        • Vavilala MS
        Cardiac dysfunction following brain death in children: prevalence, normalization, and transplantation.
        Pediatr Crit Care Med. 2015; 16: e107-e112
        • Rizwan R
        • Zafar F
        • Bryant R
        • et al.
        The number of refusals for donor organ quality does not impact heart transplant outcomes in children.
        Ann Thorac Surg. 2018; 105: 1223-1230
        • Madan S
        • Saeed O
        • Shin J
        • et al.
        Donor troponin and survival after cardiac transplantation: an analysis of the United Network of Organ Sharing registry.
        Circ Heart Fail. 2016; 9e002909
        • Kutschmann M
        • Fischer-Fröhlich CL
        • Schmidtmann I
        • et al.
        The joint impact of donor and recipient parameters on the outcome of heart transplantation in Germany after graft allocation.
        Transpl Int. 2014; 27: 152-161
        • Smits JM
        • De Pauw M
        • de Vries E
        • et al.
        Donor scoring system for heart transplantation and the impact on patient survival.
        J Heart Lung Transplant. 2012; 31: 387-397
        • Easterwood R
        • Singh RK
        • McFeely ED
        • et al.
        Pediatric cardiac transplantation using hearts previously refused for quality: a single center experience.
        Am J Transplant. 2013; 13: 1484-1490
        • Costanzo MR
        • Dipchand A
        • Starling R
        • et al.
        The international society of heart and lung transplantation guidelines for the care of heart transplant recipients.
        J Heart Lung Transplant. 2010; 29: 914-956
        • Zafar F
        • Jaquiss RD
        • Almond CS
        • et al.
        Pediatric Heart Donor Assessment Tool (PH-DAT): a novel donor risk scoring system to predict 1-year mortality in pediatric heart transplantation.
        J Heart Lung Transplant. 2018; 37: 332-339
        • Chen CW
        • Sprys MH
        • Gaffey AC
        • et al.
        Low ejection fraction in donor hearts is not directly associated with increased recipient mortality.
        J Heart Lung Transplant. 2017; 36: 611-615
        • Ison MG
        • Grossi P
        AST Infectious Diseases Community of Practice. Donor-derived infections in solid organ transplantation.
        Am J Transplant. 2013; 13: 22-30
        • Bahrami T
        • Vohra HA
        • Shaikhrezai K
        • et al.
        Intrathoracic organ transplantation from donors with meningitis: a single-center 20-year experience.
        Ann Thorac Surg. 2008; 86: 1554-1556
        • Amdani SM
        • Du W
        • Aggarwal S
        Outcome of pediatric heart transplantation in blood culture positive donors in the United States.
        Clin Transpl. 2018; 32: e13249
        • Green M
        • Covington S
        • Taranto S
        • Michaels MG
        • Wolfe C
        • Kaul DR
        Pediatrics and donor-derived disease transmission: the US OPTN experience.
        Pediatr Transplant. 2018; 22: e13115
        • Mehta SR
        • Logan C
        • Kotton CN
        • Kumar D
        • Aslam S
        Use of organs from donors with bloodstream infection, pneumonia, and influenza: results of a survey of infectious diseases practitioners.
        Transpl Infect Dis. 2017; 19: 1-8
        • Weile J
        • Eickmeyer H
        • Dreier J
        • et al.
        First case of Mycobacterium tuberculosis transmission by heart transplantation from donor to recipient.
        Int J Med Microbiol. 2013; 303: 449-451
        • Halliday N
        • Wilmore S
        • Griffiths PD
        • Neuberger J
        • Thorburn D
        Risk of transmission of H1N1 influenza by solid organ transplantation in the United Kingdom.
        Transplantation. 2012; 93: 551-554
        • Ison MG.
        Nucleic acid testing of organ donors: is the glass half empty or half full?.
        Am J Transplant. 2015; 15: 1743-1745
        • Humar A
        • Morris M
        • Blumberg E
        • et al.
        Nucleic acid testing (NAT) of organ donors: is the ”best” test the right test? A consensus conference report.
        Am J Transplant. 2010; 10: 889-899
        • Rosso F
        • Pineda JC
        • Sanz AM
        • Cedano JA
        • Caicedo LA
        Transmission of dengue virus from deceased donors to solid organ transplant recipients: case report and literature review.
        Braz J Infect Dis. 2018; 22: 63-69
        • Winston DJ
        • Vikram HR
        • Rabe IB
        • et al.
        Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features.
        Transplantation. 2014; 97: 881-889
        • Simkins J
        • Anjan S
        • Morillas-Rodriguez JA
        • et al.
        Screening for Zika virus in deceased organ donors in Florida.
        Am J Transplant. 2018; 18: 731-736
        • Chehrazi-Raffle A
        • Luu M
        • Yu Z
        • et al.
        Toxoplasma gondii serology and outcomes after heart transplantation: contention in the literature.
        Transplant Proc. 2015; 47: 1949-1953
        • Abanyie FA
        • Valice E
        • Delli Carpini KW
        • et al.
        Organ donor screening practices for Strongyloides stercoralis infection among US organ procurement organizations.
        Transpl Infect Dis. 2018; 20: e12865
        • Abanyie FA
        • Gray EB
        • Delli Carpini KW
        • et al.
        Donor-derived Strongyloides stercoralis infection in solid organ transplant recipients in the United States, 2009-2013.
        Am J Transplant. 2015; 15: 1369-1375
        • Chin-Hong PV
        • Schwartz BS
        • Bern C
        • et al.
        Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in transplant working group.
        Am J Transplant. 2011; 11: 672-680
        • Nelson JK
        • Giraldeau G
        • Montoya JG
        • Deresinski S
        • Ho DY
        • Pham M
        Donor-derived Coccidioides immitis endocarditis and disseminated infection in the setting of solid organ transplantation.
        Open Forum Infect Dis. 2016; 3: ofw086
        • Kusne S
        • Taranto S
        • Covington S
        • et al.
        Coccidioidomycosis transmission Through organ transplantation: A report of the OPTN Ad Hoc Disease Transmission Advisory Committee.
        Am J Transplant. 2016; 16: 3562-3567
        • Kaul DR
        • Covington S
        • Taranto S
        • et al.
        Solid organ transplant donors with central nervous system infection.
        Transplantation. 2014; 98: 666-670
      1. Guidance for recognizing central nervous system infections in potential deceased organ donors. Available at:https://optn.transplant.hrsa.gov/resources/guidance/guidance-for-recognizing-central-nervous-system-infections-in-potential-deceased-organ-donors/.

        • Laur O
        • Brisco MA
        • Kula AJ
        • et al.
        The impact of donor and recipient renal dysfunction on cardiac allograft survival: insights Into reno-cardiac interactions.
        J Card Fail. 2016; 22: 368-375
        • Taghavi S
        • Jayarajan SN
        • Wilson LM
        • Komaroff E
        • Testani JM
        • Mangi AA
        Cardiac transplantation can be safely performed using selected diabetic donors.
        J Thorac Cardiovasc Surg. 2013; 146: 442-447
        • Guihaire J
        • Noly PE
        • Martin A
        • et al.
        Impact of donor comorbidities on heart transplant outcomes in the modern era.
        Interact Cardiovasc Thorac Surg. 2017; 24: 898-904
        • Odish M
        • Chen M
        • Kim A
        • Floreth T
        Acquired donor peanut allergy From lung transplantation resulting in respiratory failure: A case report.
        Transplant Proc. 2018; 50: 4085-4086
        • Huang S
        • Tang Y
        • Zhu Z
        • et al.
        Outcomes of organ transplantation from donors with a cancer history.
        Med Sci Monit. 2018; 24: 997-1007
        • Nalesnik MA
        • Woodle ES
        • Dimaio JM
        • et al.
        Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.
        Am J Transplant. 2011; 11: 1140-1147
        • Gambino A
        • Torregrossa G
        • Feltrin G
        • Toscano G
        • Gerosa G
        Heart donors with underlying genetic syndromes.
        J Heart Lung Transplant. 2010; 29: 588-589
        • Orioles A
        • Morrison WE
        • Rossano JW
        • et al.
        An under-recognized benefit of cardiopulmonary resuscitation: organ transplantation.
        Crit Care Med. 2013; 41: 2794-2799
        • Galeone A
        • Varnous S
        • Lebreton G
        • et al.
        Impact of cardiac arrest resuscitated donors on heart transplant recipients’ outcome.
        J Thorac Cardiovasc Surg. 2017; 153: 622-630
        • L'Ecuyer T
        • Sloan K
        • Tang L
        Impact of donor cardiopulmonary resuscitation on pediatric heart transplant outcome.
        Pediatr Transplant. 2011; 15: 742-745
        • Conway J
        • Manlhiot C
        • Kirk R
        • Edwards LB
        • McCrindle BW
        • Dipchand AI
        Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation.
        J Heart Lung Transplant. 2014; 33: 241-251
        • Cheng A
        • Schumer EM
        • Trivedi JR
        • Van Berkel VH
        • Massey HT
        • Slaughter MS
        Does Donor cardiopulmonary resuscitation Time Affect Heart Transplantation Outcomes and Survival?.
        Ann Thorac Surg. 2016; 102: 751-758
        • West S
        • Soar J
        • Callaway CW
        The viability of transplanting organs from donors who underwent cardiopulmonary resuscitation: A systematic review.
        Resuscitation. 2016; 108: 27-33
        • Conway J
        • Chin C
        • Kemna M
        • et al.
        Donors’ characteristics and impact on outcomes in pediatric heart transplant recipients.
        Pediatr Transplant. 2013; 17: 774-781
        • Quintana-Quezada RA
        • Rajapreyar I
        • Postalian-Yrausquin A
        • et al.
        Clinical factors implicated in primary graft dysfunction After heart transplantation: A single-center experience.
        Transplant Proc. 2016; 48: 2168-2171
        • Angleitner P
        • Kaider A
        • Gökler J
        • et al.
        High-dose catecholamine donor support and outcomes after heart transplantation.
        J Heart Lung Transplant. 2018; 37: 596-603
        • Nixon JL
        • Kfoury AG
        • Brunisholz K
        • et al.
        Impact of high-dose inotropic donor support on early myocardial necrosis and outcomes in cardiac transplantation.
        Clin Transpl. 2012; 26: 322-327
        • Benck U
        • Hoeger S
        • Brinkkoetter PT
        • et al.
        Effects of donor pre-treatment with dopamine on survival after heart transplantation: a cohort study of heart transplant recipients nested in a randomized controlled multicenter trial.
        J Am Coll Cardiol. 2011; 58: 1768-1777
        • Madan S
        • Saeed O
        • Vlismas P
        • et al.
        Outcomes After transplantation of donor hearts With improving left ventricular systolic dysfunction.
        J Am Coll Cardiol. 2017; 70: 1248-1258
        • Richmond ME
        • Easterwood R
        • Singh RK
        • et al.
        Low-dose donor dopamine is associated With a decreased risk of right heart failure in pediatric heart transplant recipients.
        Transplantation. 2016; 100: 2729-2734
        • Fiorelli AI
        • Stolf NAG
        • Pego-Fernandes PM
        • et al.
        Recommendations for use of marginal donors in heart transplantation: Brazilian Association of Organs Transplantation guideline.
        Transplant Proc. 2011; 43: 211-215
        • D'Ancona G
        • Santise G
        • Falletta C
        • et al.
        Primary graft failure after heart transplantation: the importance of donor pharmacological management.
        Transplant Proc. 2010; 42: 710-712
        • Khush KK
        • Menza R
        • Nguyen J
        • Zaroff JG
        • Goldstein BA
        Donor predictors of allograft use and recipient outcomes after heart transplantation.
        Circ Heart Fail. 2013; 6: 300-309
        • Feldman A
        • Marcelino CAG
        • Beneli Prado L
        • et al.
        Reasons for refusing a donor heart for transplantation in Brazil.
        Clin Transpl. 2016; 30: 774-778
        • Cohen O
        • De La Zerda DJ
        • Beygui R
        • Hekmat D
        • Laks H
        Donor brain death mechanisms and outcomes After heart transplantation.
        Transplant Proc. 2007; 39: 2964-2969
        • Kirk R
        • Dipchand AI
        • Edwards LB
        • et al.
        The Registry of the International Society for Heart and Lung Transplantation. fifteenth pediatric heart transplantation report—2012.
        J Heart Lung Transplant. 2012; 31: 1065-1072
        • Schumacher KR
        • Almond C
        • Singh TP
        • et al.
        Predicting graft loss by 1 year in pediatric heart transplantation candidates: an analysis of the Pediatric Heart Transplant Study database.
        Circulation. 2015; 131: 890-898
        • Silva JNA
        • Canter CE
        • Singh TP
        • et al.
        Outcomes of heart transplantation using donor hearts from infants with sudden infant death syndrome.
        J Heart Lung Transplant. 2010; 29: 1226-1230
        • Venkateswaran RV
        • Townend JN
        • Wilson IC
        • Mascaro JG
        • Bonser RS
        • Steeds RP
        Echocardiography in the potential heart donor.
        Transplantation. 2010; 89: 894-901
        • Chen S
        • Selamet Tierney ES
        • Khush KK
        • et al.
        Reliability of echocardiographic measurements of left ventricular systolic function in potential pediatric heart transplant donors.
        J Heart Lung Transplant. 2015; 34: 100-106
        • Khush KK
        • Nguyen J
        • Goldstein BA
        • McGlothlin DP
        • Zaroff JG
        Reliability of transthoracic echocardiogram interpretation in potential adult heart transplant donors.
        J Heart Lung Transplant. 2015; 34: 266-269
        • Khush KK
        • Menza R
        • Nguyen J
        • Goldstein BA
        • Zaroff JG
        • Drew BJ
        Electrocardiographic characteristics of potential organ donors and associations with cardiac allograft use.
        Circ Heart Fail. 2012; 5: 475-483
        • Dorent R
        • Gandjbakhch E
        • Goéminne C
        • et al.
        Assessment of potential heart donors: A statement from the French heart transplant community.
        Arch Cardiovasc Dis. 2018; 111: 126-139
        • Leong D
        • Aintablian T
        • Kittleson M
        • et al.
        Prolonged corrected QT interval in the donor heart: is there a risk?.
        Clin Transpl. 2017; : 31
        • Boccheciampe N
        • Audibert G
        • Rangeard O
        • et al.
        Serum troponin Ic values in organ donors are related to donor myocardial dysfunction but not to graft dysfunction or rejection in the recipients.
        Int J Cardiol. 2009; 133: 80-86
        • Khush KK
        • Menza RL
        • Babcock WD
        • Zaroff JG
        Donor cardiac troponin I levels do not predict recipient survival after cardiac transplantation.
        J Heart Lung Transplant. 2007; 26: 1048-1053
        • Venkateswaran RV
        • Ganesh JS
        • Thekkudan J
        • et al.
        Donor cardiac troponin-I: a biochemical surrogate of heart function.
        Eur J Cardio Thorac Surg. 2009; 36: 286-292
        • Szarszoi O
        • Besik J
        • Smetana M
        • et al.
        Biomarkers of cellular apoptosis and necrosis in donor myocardium are not predictive of primary graft dysfunction.
        Physiol Res. 2016; 65: 251-257
        • Vorlat A
        • Conraads VM
        • Jorens PG
        • et al.
        Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantation.
        J Heart Lung Transplant. 2012; 31: 579-584
        • Amir NL
        • Gerber IL
        • Edmond JJ
        • Langlands JM
        • Richards AM
        • Ruygrok PN
        Plasma B-type natriuretic peptide levels in cardiac donors.
        Clin Transpl. 2009; 23: 174-177
        • Dronavalli VB
        • Banner NR
        • Bonser RS
        Assessment of the potential heart donor: a role for biomarkers?.
        J Am Coll Cardiol. 2010; 56: 352-361
        • Lieppman K
        • Kramer-Clark L
        • Tobias JD
        Plasma B-type natriuretic peptide monitoring to evaluate cardiovascular function prior to organ procurement in patients with brain death.
        Pediatr Anesth. 2008; 18: 852-856
        • Rodrigues W
        • Carr M
        • Ridout D
        • et al.
        Total donor ischemic time: relationship to early hemodynamics and intensive care morbidity in pediatric cardiac transplant recipients.
        Pediatr Crit Care Med. 2011; 12: 660-666
        • Ford MA
        • Almond CS
        • Gauvreau K
        • et al.
        Association of graft ischemic time with survival after heart transplant among children in the United States.
        J Heart Lung Transplant. 2011; 30: 1244-1249
        • Kirk R
        • Naftel D
        • Hoffman TM
        • et al.
        Outcome of pediatric patients With dilated cardiomyopathy listed for transplant: A multi-institutional study.
        J Heart Lung Transplant. 2009; 28: 1322-1328
        • Vanderlaan RD
        • Manlhiot C
        • Conway J
        • Honjo O
        • McCrindle BW
        • Dipchand AI
        Perioperative factors associated with in-hospital mortality or retransplantation in pediatric heart transplant recipients.
        J Thorac Cardiovasc Surg. 2014; 148: 282-289
        • Russo MJ
        • Chen JM
        • Sorabella RA
        • et al.
        The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database.
        J Thorac Cardiovasc Surg. 2007; 133: 554-559
        • Crawford TC
        • Magruder JT
        • Grimm JC
        • et al.
        The paradoxical relationship Between donor distance and survival After heart transplantation.
        Ann Thorac Surg. 2017; 103: 1384-1391
        • Latchana N
        • Peck JR
        • Whitson B
        • Black SM
        Preservation solutions for cardiac and pulmonary donor grafts: a review of the current literature.
        J Thorac Dis. 2014; 6: 1143-1149
        • Messer S
        • Ardehali A
        • Tsui S
        Normothermic donor heart perfusion: current clinical experience and the future.
        Transpl Int. 2015; 28: 634-642
        • Kirk R
        • Dipchand AI.
        Continuous donor perfusion for heart preservation.
        Prog Pediatr Cardiol. 2017; 46: 15-18
        • Ardehali A
        • Esmailian F
        • Deng M
        • et al.
        Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial.
        Lancet. 2015; 385: 2577-2584
        • García Sáez D
        • Zych B
        • Sabashnikov A
        • et al.
        Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile.
        Ann Thorac Surg. 2014; 98: 2099-2105
        • Essien E-OI
        • Parimi N
        • Gutwald-Miller J
        • Nutter T
        • Scalea TM
        • Stein DM
        Organ dysfunction and failure following brain death do not preclude successful donation.
        World J Surg. 2017; 41: 2933-2939
        • Kotloff RM
        • Blosser S
        • Fulda GJ
        • et al.
        Management of the potential organ donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus statement.
        Crit Care Med. 2015; 43: 1291-1325
        • Westphal GA
        • Slaviero TA
        • Montemezzo A
        • et al.
        The effect of brain death protocol duration on potential donor losses due to cardiac arrest.
        Clin Transpl. 2016; 30: 1411-1416
        • Abuanzeh R
        • Hashmi F
        • Dimarakis I
        • et al.
        Early donor management increases the retrieval rate of hearts for transplantation in marginal donors.
        Eur J Cardio Thorac Surg. 2015; 47: 72-77
        • Casartelli M
        • Bombardini T
        • Simion D
        • Gaspari MG
        • Procaccio F
        Wait, treat and see: echocardiographic monitoring of brain-dead potential donors with stunned heart.
        Cardiovasc Ultrasound. 2012; 10: 25
        • Dark JH.
        Safe and effective use of the extended donor heart.
        Eur J Cardio Thorac Surg. 2015; 47: 78-79
        • Inaba K
        • Branco BC
        • Lam L
        • et al.
        Organ donation and time to procurement: late is not too late.
        J Trauma. 2010; 68: 1362-1366
        • Christmas AB
        • Bogart TA
        • Etson KE
        • et al.
        The reward is worth the wait: a prospective analysis of 100 consecutive organ donors.
        Am Surg. 2012; 78: 296-299
        • Fukushima N
        • Ono M
        • Saiki Y
        • Minami M
        • Konaka S
        • Ashikari J
        Donor evaluation and management system (medical consultant system) in Japan: experience from 200 consecutive brain-dead organ donation.
        Transplant Proc. 2013; 45: 1327-1330
        • Venkateswaran RV
        • Dronavalli V
        • Lambert PA
        • et al.
        The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy.
        Transplantation. 2009; 88: 582-588
        • Abdelnour T
        • Rieke S.
        Relationship of hormonal resuscitation therapy and central venous pressure on increasing organs for transplant.
        J Heart Lung Transplant. 2009; 28: 480-485
        • Chudoba P
        • Krajewski W
        • Wojciechowska J
        • Kamińska D
        Brain death-associated pathological events and therapeutic options.
        Adv Clin Exp Med. 2017; 26: 1457-1464
        • Kilic A
        • Weiss ES
        • Allen JG
        • et al.
        Simple score to assess the risk of rejection after orthotopic heart transplantation.
        Circulation. 2012; 125: 3013-3021
        • Stehlik J
        • Feldman DS
        • Brown RN
        • et al.
        Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis.
        J Heart Lung Transplant. 2010; 29: 291-298
        • Trivedi JR
        • Cheng A
        • Ising M
        • Lenneman A
        • Birks E
        • Slaughter MS
        Heart transplant survival based on recipient and donor risk scoring: a UNOS Database Analysis.
        ASAIO J. 2016; 62: 297-301
        • Huang J
        • Trinkaus K
        • Huddleston CB
        • Mendeloff EN
        • Spray TL
        • Canter CE
        Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics.
        J Heart Lung Transplant. 2004; 23: 716-722
        • Bae S
        • Massie AB
        • Luo X
        • Anjum S
        • Desai NM
        • Segev DL
        Changes in discard rate After the introduction of the kidney donor profile index (KDPI).
        Am J Transplant. 2016; 16: 2202-2207
        • Feingold B
        • Webber SA
        • Bryce CL
        • et al.
        Comparison of listing strategies for allosensitized heart transplant candidates requiring transplant at high urgency: a decision model analysis.
        Am J Transplant. 2015; 15: 427-435
        • Godown J
        • Kirk R
        • Joong A
        • et al.
        Variability in donor selection among pediatric heart transplant providers: results from an international survey.
        Pediatr Transplant. 2019; 23: e13417
        • Feingold B
        • Bowman P
        • Zeevi A
        • et al.
        Survival in allosensitized children after listing for cardiac transplantation.
        J Heart Lung Transplant. 2007; 26: 565-571
        • Urschel S
        • Larsen IM
        • Kirk R
        • et al.
        ABO-incompatible heart transplantation in early childhood: an international multicenter study of clinical experiences and limits.
        J Heart Lung Transplant. 2013; 32: 285-292
        • Schnier KE
        • Cox JC
        • McIntyre C
        • Ruhil R
        • Sadiraj V
        • Turgeon N
        Transplantation at the nexus of behavioral economics and health care delivery.
        Am J Transplant. 2013; 13: 31-35
        • Howard DH
        Why do transplant surgeons turn down organs?.
        J Health Econ. 2002; 21: 957-969
        • Axelrod DA.
        Balancing accountable care with risk aversion: transplantation as a model.
        Am J Transplant. 2013; 13: 7-8
        • Spranca M
        • Minsk E
        • Baron J
        Omission and commission in judgment and choice.
        J Exp Soc Psychol. 1991; 27: 76-105
        • Samuelson W
        • Zeckhauser R.
        Status quo bias in decision making.
        J Risk Uncertain. 1988; 1: 7-59
        • Kahneman D
        • Tversky A.
        Choices, values and frames.
        Ann Psychol. 1984; 39: 341-350
      2. Spanish ONT. Organ distribution criteria. Available at:http://www.ont.es/infesp/CriterioDeDistribucion/CriteriosdistribuciónCorazón2019.pdf.

        • Baron J
        • Hershey JC.
        Outcome bias in decision evaluation.
        J Pers Soc Psychol. 1988; 54: 569-579
        • Davies RR
        • Haldeman S
        • Pizarro C
        Regional variation in survival before and after pediatric heart transplantation—an analysis of the UNOS database.
        Am J Transplant. 2013; 13: 1817-1829
        • Dunbavand A
        • Poinard C
        • Metras D
        • Cohen S
        • Chalem Y
        • Tuppin P
        [Geographic variations in access to heart transplantation in France].
        Arch Mal Coeur Vaiss. 2002; 95: 1143-1149
        • Nguyen VP
        • Givens RC
        • Cheng RK
        • et al.
        Effect of regional competition on heart transplant waiting list outcomes.
        J Heart Lung Transplant. 2016; 35: 986-994
        • Israni AK
        • Zaun D
        • Rosendale JD
        • Schaffhausen C
        • Snyder JJ
        • Kasiske BL
        OPTN/SRTR 2016 annual data report: deceased organ donation.
        Am J Transplant. 2018; 18: 434-463
        • McGlade D
        • Rae G
        • McClenahan C
        • Pierscionek B
        Regional and temporal variations in organ donation across the UK (secondary analyses of databases).
        BMJ Open. 2011; 1e000055
        • Godown J
        • McKane M
        • Wujcik K
        • Mettler BA
        • Dodd DA
        Expanding the donor pool: regional variation in pediatric organ donation rates.
        Pediatr Transplant. 2016; 20: 1093-1097
        • Davies RR
        • Bano M
        • Butts RJ
        • Jaquiss RDB
        • Kirk R
        Donor organ turn-downs and outcomes after listing for pediatric heart transplant.
        J Heart Lung Transplant. 2019; 38: 241-251
        • Park CS
        • Villa CR
        • Lorts A
        • et al.
        Is there an optimal organ acceptance rate for pediatric heart transplantation: “A sweet spot”?.
        Pediatr Transplant. 2018; 22: e13149